Triomics
Generative AI-Powered Platform for Cancer Care Providers
Triomics is a generative AI platform designed for oncology workflows at cancer care providers, health systems, and life sciences organizations. It uses its oncology-tuned AI model, OncoLLM, to process unstructured clinical records and deliver actionable insights such as clinical trial matching, patient summaries, and automated cancer registry curation directly into provider workflows. The platform is deployed at major institutions including Memorial Sloan Kettering, Mount Sinai, and Yale Cancer Center.
Triomics ingests all clinical documents from an EHR using OncoLLM, transforms unstructured data into real-time insights, and delivers them through custom AI agents directly into provider workflows.
Cancer care providers, health systems, and life sciences organizations
Background.
- Status
- launched
- Business model
- unknown
- Company
- Triomics
Similar projects.
Editorial take on the space this project sits in — momentum signals, adjacent moves, our call on whether the wedge is real. Get pinged when we publish a new read or when the landscape shifts.
Have a take on this space?
Tell us what you’d build differently, where you think the incumbents miss, or what we’ve gotten wrong about this project. Comments + reactions are coming soon.